Podcasts about Cochlear

Inspire | Influence | Impact As Engineers Australia celebrates International Women in Engineering Day under the theme Engineering Intelligence, our latest 20 Years of Women on Boards podcast with Dr Bronwyn Evans AM provides a powerful reminder that engineering is about far more than technology. One of Australia's most respected engineers, Bronwyn was the first female CEO of both Engineers Australia and Standards Australia, has held senior executive roles at Cochlear and GE Healthcare, and now serves as a non-executive director across a range of sectors. She is also a long-standing Women on Boards member. In conversation with Claire Braund, Bronwyn reflects on a career shaped by curiosity, pragmatism and a willingness to seize opportunities. Growing up in Wollongong during a period of significant industrial growth, she developed an appreciation for practical problem-solving, multicultural collaboration and the belief that education could create opportunities regardless of background. A recurring theme throughout the discussion is the value engineers bring to leadership and governance. Bronwyn believes engineers are uniquely equipped for board roles because of their systems thinking, ability to understand complex problems and disciplined approach to decision-making. While engineers are often associated with technical expertise, she notes that many progress into executive leadership, strategy, operations and transformation roles, making them valuable contributors in the boardroom. The conversation also explores the evolution of technology, from punch-card programming and early automation systems through to today's AI-enabled world. Having completed a PhD in real-time robotic control systems, Bronwyn reflects on how rapidly technology has evolved and why engineers must continue to adapt and embrace new tools while maintaining a focus on solving meaningful problems. As discussions around artificial intelligence continue to dominate board and executive agendas, Bronwyn offers a thoughtful perspective on both the opportunities and challenges ahead. She highlights the importance of maintaining trust, integrity and standards while recognising that AI will continue to reshape how organisations operate and innovate. Bronwyn also reflects on the important role Women on Boards has played throughout her governance journey. Having joined WOB in 2007 while working at Cochlear, she describes the organisation as an egalitarian community where women can test ideas, learn from one another and access opportunities. She recalls the influence of early WOB conferences and the insights gained from global discussions about increasing women's representation on boards. Looking to the future, Bronwyn sees the next challenge as increasing diversity in all its forms, including bringing younger women, culturally diverse women and more engineers into boardrooms. Her message is clear: diverse perspectives lead to better thinking, better governance and better outcomes. Asked to summarise her journey over the past two decades, Bronwyn chose three words: opportunistic, enjoyable and learning. They are fitting reflections from a leader who has spent her career embracing new challenges, championing engineering and helping create pathways for future generations of women leaders. Learn more about Women on Boards

WE ARE GRATEFUL TO: JOEY FRIED CORP AND FOGLER, RUBINOFF FOR THEIR GENEROUS SPONSORSHIP! Welcome to The Avrum Rosensweig Show. There are some books that inform. There are others that inspire. And then there are those rare books that have the power to change the way we see other people—and ourselves. In this moving and deeply personal conversation, Avrum Rosensweig sits down with renowned educator, speaker, and author Michal Horowitz to discuss her remarkable new book, 'Abled: Living With a Disability, A Torah View.' Born and raised in Toronto and trained as an audiologist, Michal began experiencing severe hearing loss as a young adult. What could have become a story defined by limitation instead became a life of extraordinary purpose, faith, resilience, and Torah teaching. Together, Avrum and Michal explore what it means to live in a hearing world while navigating profound hearing impairment, how Judaism understands disability and human dignity, and why every person—regardless of ability—reflects the image of God. This is a conversation about courage. It is a conversation about faith. And ultimately, it is a conversation about what it truly means to live an abled life. Riveting Moments from This Interview 08:35 — "I felt like my body had betrayed me." Avrum shares the emotional aftermath of his first heart attack, leading to a profound discussion about illness, loss, and identity. 15:40 — The Moment Michal Realized She Was Losing Her Hearing Michal recounts the frightening early signs of hearing loss and the long journey toward diagnosis and acceptance. 24:15 — What Hearing People Don't Understand About Hearing Loss A powerful conversation about loneliness, stigma, exclusion, and the hidden struggles of living with hearing impairment. 36:50 — Can Disability Become a Spiritual Gift? Michal explains how Torah transformed her understanding of suffering, purpose, and human dignity. 49:20 — The Cochlear Implant Debate Michal speaks candidly about her son's success with cochlear implants and why she remains hesitant to undergo the procedure herself. In This Episode • Living with severe hearing loss • The emotional realities of disability • Torah perspectives on dignity and inclusion • Faith, resilience, and personal growth • Tinnitus and speech discrimination • Cochlear implants and medical technology • Parenting, teaching, and inspiring others • Seeing God's image in every human being If you enjoyed this conversation, please Like, Subscribe, and Share. #MichalHorowitz #HearingLoss #Disability #AbleBook #Torah #Judaism #Faith #HumanDignity #CochlearImplants #AvrumRosensweigShow #MichalHorowitz #HearingLoss #HearingImpairment #DisabilityAwareness #DisabilityInclusion #CochlearImplants #HumanDignity #JewishLife #TorahWisdom #Judaism #FaithAndResilience #SpiritualGrowth #JewishAuthor #JewishEducation #InvisibleDisability #LivingWithDisability #InspirationalStories #ImageOfGod ——

WE ARE GRATEFUL TO: JOEY FRIED CORP AND FOGLER, RUBINOFF FOR THEIR GENEROUS SPONSORSHIP! Welcome to The Avrum Rosensweig Show. There are some books that inform. There are others that inspire. And then there are those rare books that have the power to change the way we see other people—and ourselves. In this moving and deeply personal conversation, Avrum Rosensweig sits down with renowned educator, speaker, and author Michal Horowitz to discuss her remarkable new book, 'Abled: Living With a Disability, A Torah View.' Born and raised in Toronto and trained as an audiologist, Michal began experiencing severe hearing loss as a young adult. What could have become a story defined by limitation instead became a life of extraordinary purpose, faith, resilience, and Torah teaching. Together, Avrum and Michal explore what it means to live in a hearing world while navigating profound hearing impairment, how Judaism understands disability and human dignity, and why every person—regardless of ability—reflects the image of God. This is a conversation about courage. It is a conversation about faith. And ultimately, it is a conversation about what it truly means to live an abled life. Riveting Moments from This Interview 08:35 — "I felt like my body had betrayed me." Avrum shares the emotional aftermath of his first heart attack, leading to a profound discussion about illness, loss, and identity. 15:40 — The Moment Michal Realized She Was Losing Her Hearing Michal recounts the frightening early signs of hearing loss and the long journey toward diagnosis and acceptance. 24:15 — What Hearing People Don't Understand About Hearing Loss A powerful conversation about loneliness, stigma, exclusion, and the hidden struggles of living with hearing impairment. 36:50 — Can Disability Become a Spiritual Gift? Michal explains how Torah transformed her understanding of suffering, purpose, and human dignity. 49:20 — The Cochlear Implant Debate Michal speaks candidly about her son's success with cochlear implants and why she remains hesitant to undergo the procedure herself. In This Episode • Living with severe hearing loss • The emotional realities of disability • Torah perspectives on dignity and inclusion • Faith, resilience, and personal growth • Tinnitus and speech discrimination • Cochlear implants and medical technology • Parenting, teaching, and inspiring others • Seeing God's image in every human being If you enjoyed this conversation, please Like, Subscribe, and Share. #MichalHorowitz #HearingLoss #Disability #AbleBook #Torah #Judaism #Faith #HumanDignity #CochlearImplants #AvrumRosensweigShow #MichalHorowitz #HearingLoss #HearingImpairment #DisabilityAwareness #DisabilityInclusion #CochlearImplants #HumanDignity #JewishLife #TorahWisdom #Judaism #FaithAndResilience #SpiritualGrowth #JewishAuthor #JewishEducation #InvisibleDisability #LivingWithDisability #InspirationalStories #ImageOfGod ——

Francis Hall (Faceboy) hosts his friends Calvin Williams and Dezi Liese and explore a variety of topics including Cochlear implantation and the controversies around the procedure.

In the wake of the budget and the proposed CGT changes, there has been plenty of spirited debate about the future of growth investing in our great country. And rightly so.  But let's get real. Whatever we might think about the changes, Aussies will still create and invest in great growth businesses. It's in our blood.  No tax change is going to completely crush home-grown innovation - the very innovation which brought us the Coolgardie cooler, the Hills Hoist, the Cochlear implant, and WiFi. Oh, and Tim Tams... mustn't forget the Tim Tams.  Typically, these great growth stories are born from the small-cap end of the market, so in this episode, Livewire's Chris Conway is joined by Oscar Oberg from Wilson Asset Management and Alex Shevelev from Forager Funds Management, who each bring three stocks they believe have big potential.  That's right, it's going to be wall-to-wall buys for this episode so strap in, and let's go! This episode was filmed on Wednesday, 20th May 2026.

Tango twins, Cochlear gene therapy, Inadequate transit, Creative constraints, Mistaken guy-dentity. Jennifer, Angie, and Bradley discuss the curated links for the week of 5/15/2026. Please consider supporting this ad-free content on Patreon.

The guys discuss Cochlear's horrific profit downgrade, Firmus IPO hopes up in smoke (for now), self driving to challenge air travel, battery technology goes large and Uber and Expedia get close. 00:00 - Blackbird's Sunrise Start Up Event13:40 - Firmus32:50 - Uber x Expedia42:55 - Public Transport44:55 - CATL53:36 - Self Driving vs. Flying1:02:46 - Experience Economy1:12:57 - Cochlea Deep Dive Thanks for listening! Join us on LinkedIn: https://www.linkedin.com/company/the-contrarians-with-adam-and-adir-podcastSee omnystudio.com/listener for privacy information.

Graham Witcomb and Nick Cummings join John Addis on this week's episode of Stock Take to discuss what's going on at Cochlear, and whether the Atlanta Braves are a swing worth taking.See omnystudio.com/listener for privacy information.

– Real time reaction on Cochlear – Some real talk on oil and gas royalties? – Is it time to invest internationally outside the US?See omnystudio.com/listener for privacy information.

Market volatility is back on the radar this week as geopolitical tensions drive oil prices higher and keep global investors on edge. While the Wall Street had a strong month driven by the AI sector, the local market is facing a more challenging period, headlined by downgrades across the banks and by the biggest story this week in Cochlear's (ASX:COH) over 40% decline. In this week's wrap, Sophia and Will cover:the impact of rising crude oil prices and stalled peace talks on global investor sentimentwhy the ASX is lagging behind the AI-driven rally seen in US marketsa look at the recent performance of the energy and financial sectors in AustraliaCochlear's (ASX:COH) 40% tumble what it means for long-term shareholders.

Cochlear, the ASX-listed hearing implant company, has seen its share price plummet 36% - its biggest one day fall in 30 YEARS. Intrepid Travel, the Aussie tour group operator, is buying its way to billion dollar status… by snapping up French rival Altai. Adobe has announced a massive $25 billion share buyback program to give investors confidence in its future…despite the launch of Claude Design and co. _ Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.See omnystudio.com/listener for privacy information.

The local market slipped for a third straight day, falling 0.6% as hopes for a US-Iran peace deal faded. With negotiations stalled and the Strait of Hormuz closed once again, oil prices have reclaimed the 100 USD mark for the first time in weeks. The index has now retreated 2.5% from its recent mid-April highs, erasing a significant chunk of the month’s recovery gains. Energy stocks were the sole bright spot, jumping 3% on the back of soaring crude. Santos lifted 3.5% after maintaining its annual guidance, while Karoon Energy led the pack with an 8% surge. Cochlear plunged another 4% to hit a decade-low, extending its catastrophic 63% year-to-date decline. Retailer Temple & Webster also cratered 8% to a two-year low following a surprise leadership shake-up. Steve Daghlian and Laura Besarati are Market Analysts at CommSec. Each episode, they break down the day's market movements and explain what the numbers really mean. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

The Australian sharemarket slipped 1.1 per cent, yet remains within reach of a record high, continuing its recovery from March's downturn as super funds rebound and long-term gains hold steady. In this episode of SBS On the Money, Ricardo Gonçalves unpacks the day's biggest moves, including Cochlear's dramatic 40 per cent fall to a 10-year low after a profit warning tied to weak US consumer confidence and global uncertainty. Portfolio manager James Gerrish from Market Partners joins the conversation to discuss whether other companies will also be hit by the war in the Middle-East.

The Aussie share market tumbled more than 1% on Wednesday, marking its worst day in five weeks, as investors reacted to ongoing uncertainty over US-Iran peace talks. The financial sector led the decline, with major banks falling between 2-2.5%, while Cochlear shares plunged 40% after a significant profit downgrade. Treasury Wine Estates was a rare bright spot, jumping 16.5% on a major business restructure and positive trading update. Steve Daghlian and Laura Besarati are Market Analysts at CommSec. Each episode, they break down the day's market movements and explain what the numbers really mean. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Federal debt nears $1 trillion as broad NDIS changes are unveiled, Cochlear shares plunge up to 40 per cent after a sales warning. Plus, the government flags significant tax reform in the upcoming budget.See omnystudio.com/listener for privacy information.

This is the Fear & Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes. ASX tumbles on Cochlear downgrade Govt secures 200m litres of diesel Treasury Wine Estates’ major restructure Jackie Henderson alleges bullying Anthropic investigating unauthorised access Join our free daily newsletter here.Find out more: https://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

This is the Fear & Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes. ASX tumbles on Cochlear downgrade Govt secures 200m litres of diesel Treasury Wine Estates’ major restructure Jackie Henderson alleges bullying Anthropic investigating unauthorised access Join our free daily newsletter here.Support the show: http://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

Thursday 23 April 2026 The top five business stories in five minutes, with Sean Aylmer and Michael Thompson. NDIS overhaul Rental market reaches breaking point Cochlear tumbles 41pc Corporate Travel Management debacle worsens Can AI be blamed for murder? Hit follow on the podcast so you don’t miss the latest news. Join our free daily newsletter here. And don’t miss the latest episode of How Do They Afford That? - if you lost your job tomorrow, would you be okay? Get the episode from APPLE, SPOTIFY, or anywhere you listen to podcasts.Support the show: http://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

The Australian sharemarket slipped 1.1 per cent, yet remains within reach of a record high, continuing its recovery from March's downturn as super funds rebound and long-term gains hold steady. In this episode of SBS On the Money, Ricardo Gonçalves unpacks the day's biggest moves, including Cochlear's dramatic 40 per cent fall to a 10-year low after a profit warning tied to weak US consumer confidence and global uncertainty. Portfolio manager James Gerrish from Market Partners joins the conversation to discuss whether other companies will also be hit by the war in the Middle-East.

Welcome to this Thursday Financial Planning session, where we break down one of the most important times in the investing calendar — ASX reporting season.With February marking half-year results (and August covering full-year results), listed companies provide updates on earnings, dividends, business performance, and forward guidance. These updates can significantly impact share prices — sometimes in ways that surprise even experienced investors.In this episode, we unpack:What reporting season is and why it mattersHow earnings and dividends influence share pricesWhy markets don't always react logically to “good” resultsThe strongest performing sectors so far — including banksWhy some healthcare and retail stocks have struggledHow expectations, not just results, drive market reactionsWe also look at real examples from this reporting season, including:BHP – Up strongly after pivoting toward copper and benefiting from the clean energy theme, alongside increased dividends.Commonwealth Bank – Posting strong results as higher interest rates continue to support bank profitability.Pro Medicus – Delivering solid growth in revenue and profit, yet seeing a sharp share price decline after missing high market expectations.We also touch on the performance of NAB, Temple & Webster, ANZ, CSL, and Cochlear, highlighting how sectors like banking, mining, healthcare, retail, and tech are navigating current market conditions.Most importantly, we discuss what investors should actually focus on during reporting season — CEO commentary, forward guidance, sector trends, diversification, and long-term positioning.If you hold individual shares (not just ETFs), this is one of the most critical periods of the year. Expect volatility. Expect double-digit moves. And most importantly, understand why they're happening.Tune in to stay informed, stay strategic, and stay ahead of the market conversation.

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howett about the hearing implant maker's latest results, the link between hearing loss and dementia and the impact the higher Australian dollar will have on its earnings. Plus Mahjabeen Zaman from ANZ looks at the drivers of the surging currency and market implications.

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes. ASX drops on tech sell-off Angus Taylor wins Lib spill Austal, Cochlear, Webjet tumble ICE agents out of Minnesota First Aussie gold at Winter Olympics Join our free daily newsletter here.Support the show: http://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howett about the hearing implant maker's latest results, the link between hearing loss and dementia and the impact the higher Australian dollar will have on its earnings. Plus Mahjabeen Zaman from ANZ looks at the drivers of the surging currency and market implications.

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes. ASX drops on tech sell-off Angus Taylor wins Lib spill Austal, Cochlear, Webjet tumble ICE agents out of Minnesota First Aussie gold at Winter Olympics Join our free daily newsletter here.Find out more: https://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

The ASX 200 slipped about 2.3 % on Friday, the worst day in ten months, as every sector posted losses. Weak US tech, falling commodity prices and concerns over the new Fed chair amplified the sell‑off. CBA rallied 6.4 % after a rebound, but WEB Travel plunged 30 % following a tax‑audit notice. Look ahead to US jobs and inflation data, the RBA’s May rate outlook, and a busy Australian reporting week featuring CBA, AMP, IAG, ANZ, Westpac, Evolution, Northern Star, CSL and Cochlear. Also watch Japan’s snap election for possible market moves. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Send us a textAn escaped mental patient embarks on a murder spree after escaping from an institution in 1987 Oakland, CA. He encounters a group of punks and they all regale each other with tales about their shared love of movies, people, places and memories beyond our knowable universe. On Episode 695 of Trick or Treat Radio we have another Patreon Takeover, this time with EF Contentment! EF has selected the films Freaky Tales and Nightmare (1981) for us to discuss! We also talk about underdog films, video nasties, and the romantic sleaziness of big cities in the 80s. So grab your favorite 80s mixtape, equip your favorite Nazi smashing weapon, and strap on for the world's most dangerous podcast!Stuff we talk about: Patreon Takeover, EF Contentment, High Spirits, Steve Guttenberg, Liam Neeson, The Buggering, Crying Game, Neil Jordan, Blood Diner, Night Patrol, The Unknown Comic, Billy Barty, The Being, Ryan Prows, Lowlife, C.M. Punk, Justin Long, Ricardo Zarate, Mike Nichols, Bill and Ted's Bogus Journey, Stargate, DTS audio, SDDS, Brotherhood of the Wolf, Ali, The Gulp of Mexico, Skydance Paramount, Howard Dean, Mike Dukakis, Roman Polanski, G.I. Joe, “Bubba”, Univeral Healthcare, Sara Ottoman, Ryan Gosling, Half Nelson, Sugar, Anna Boden, Ryan Fleck, Freaky Tales, Captain Marvel, Go, Mystery Train, Pulp Fiction, Maniac, Scott Pilgrim vs. The World, Green Room, the punk rock hip-hop and metal scenes, Lost Boys, Ishtar, Raising Arizona, Radio Days, Tom Hanks, Sid and Nancy, Big Trouble in Little China, Breaking Away, Top 5 Underdog Movies, Roger Ebert, Repo Man, David Cronenberg, Quentin Tarantino, Megadeth, Bill and Ted's Bogus Journey, plagiarism vs. homage, Nancy Reagan, TOO $HORT, Jay Ellis, Blade, The Fury, Brian De Palma, Three Days in the Valley, Nightmare, Romano Scavolini, Video Nasty, Trick or Treats, Death Wish Club, Basket Case, Alice Sweet Alice, Astron-6, Steven Kostanski, Deathstalker, Patton Oswalt, Daniel Bernhardt, Brain Dead Studios, Once Bitten, Lake Placid, Transylvania 6-5000, Razorback, Lifeforce, Gremlins 2, The Funhouse, Demon Witch Child, Night of the Demon, Jim Carrey, and generational trauma.Support us on Patreon: https://www.patreon.com/trickortreatradioJoin our Discord Community: discord.trickortreatradio.comSend Email/Voicemail: mailto:podcast@trickortreatradio.comVisit our website: http://trickortreatradio.comStart your own podcast: https://www.buzzsprout.com/?referrer_id=386Use our Amazon link: http://amzn.to/2CTdZzKFB Group: http://www.facebook.com/groups/trickortreatradioTwitter: http://twitter.com/TrickTreatRadioFacebook: http://facebook.com/TrickOrTreatRadioYouTube: http://youtube.com/TrickOrTreatRadioInstagram: http://instagram.com/TrickorTreatRadioSupport the show

Vidcast:  https://www.instagram.com/p/DQdnYr9jZwV/An exciting, ground-breaking clinical study now shows that children born with a defective gene coding for a vital inner ear protein can have that gene  repaired and hearing restored. This phenomenally successful preliminary clinical trial was recently published in the New England Journal of Medicine.Genetic bioengineers at New York's Regeneron Pharmaceuticals loaded a normal copy of the otoferlin gene into a dual adeno-associated virus acting as a Trojan horse.  Twelve children, born without the ability to synthesize otoferlin protein, received the gene injection, dubbed DB-OTO therapy, into their inner ears at 3 clinical centers: Harvard's Mass. Eye and Ear Infirmary, UC San Diego's Children's Hospital, and University College London.  Otoferlin is necessary for the inner ear's ability to convert sound vibrations into electrical impulses.  At 24 weeks post-injection, 9 of the 12 children, 75%, regained measurable hearing.  Three, 25%, developed near normal hearing.  The gene therapy was well-tolerated without any significant side effects.This gene therapy, with further refinement and after larger clinical trials, may be a one-and-done treatment for one common form of congenital deafness. Cochlear implants will continue to be essential therapy for other types of genetic and acquired severe hearing losses pending development of other genetic and/or chemical cochlear modifications.https://www.nejm.org/doi/full/10.1056/NEJMoa2400521#deafness #children #congenital #otoferlin #dboto 

Cochlear implants are leading a revolution in the treatment of hearing loss. According to a 2022 study, only about 10% of those who qualify for cochlear implants have received them. Cost, accessibility, and lack of awareness are only some roadblocks for potential patients. At Pacific Neuroscience Institute, Dr. Courtney Voelker and Dr. Chester Griffiths are working to change that. Dr. Voelker is recognized as one of the nation's top cochlear implant surgeons, with patients as young as five months old. Dr. Griffiths is the founder of Pacific Head & Neck, a premier clinic in Los Angeles. Because hearing loss is the leading modifiable risk factor for cognitive decline, addressing it is vital. Tune in to hear how these two doctors are raising awareness about cochlear implants and making a difference in people's lives.

Zhiyong Liu discusses his paper, “Revisiting the Potency of Tbx2 Expression in Transforming Outer Hair Cells into Inner Hair Cells at Multiple Ages In Vivo,” published in Vol. 44, Issue 23 of JNeurosci, with Megan Sansevere from SfN's Journals' staff. Then, Catherine Weisz discusses her paper, “Fast Inhibition Slows and Desynchronizes Mouse Auditory Efferent Neuron Activity,” published in Vol.44 Issue 33 of JNeurosci. Find the rest of the Spotlight collection here. With special guests: Zhiyong Liu and Catherine Weisz Hosted by: Megan Sansevere On Neuro Current, we delve into the stories and conversations surrounding research published in the journals of the Society for Neuroscience. Through its publications, JNeurosci, eNeuro, and the History of Neuroscience in Autobiography, SfN promotes discussion, debate, and reflection on the nature of scientific discovery, to advance the understanding of the brain and the nervous system.  Find out more about SfN and connect with us on BlueSky, X, Instagram, and LinkedIn.

What if a cochlear implant could adapt and improve throughout a patient's lifetime? Hearing health advocate and author Gael Hannan sits down with Brendan Murray, Vice President of CI Product Portfolio at Cochlear, to discuss the launch of the Cochlear™ Nucleus® Nexa™ System. The Nexa is the first cochlear implant platform with upgradeable firmware, allowing recipients to benefit from future innovations beyond traditional sound processor upgrades.The system includes the Nucleus Nexa Implant along with the new Nucleus 8 Nexa and Kanso 3 Nexa Sound Processors. Key features include internal memory to securely store individualized hearing settings, Smart Sync for rapid restoration of maps when replacing a processor, and Dynamic Power Management for improved efficiency. The Nucleus 8 Nexa Sound Processor is also 9% smaller and 12% lighter than its predecessor, while still delivering all-day battery life.In this conversation, Murray outlines how the Nexa represents the first major cochlear implant redesign in more than 20 years, bringing advances in patient self-management, expanded diagnostic tools for clinicians, and a platform that can adapt to future hearing innovations.Press release announcing US FDA approval of Nexa Implant System: https://hearinghealthmatters.org/hearing-technologies/2025/cochlear-nexa-implant-fda-approval/Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X.https://x.com/WeekinHearinghttps://www.instagram.com/thisweekinhearing/https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howitt after the group's full-year results annoucement about the future of implants, while Stephanie Youssef discusses the role of EVs with CAR Group CEO William Elliott; while Grady Wulff from Bell Direct goes through the numerous records the Australian sharemarket hit during the week.

US stocks pulled back from record highs as investors digested fresh inflation data, with Treasuries sliding after wholesale price figures dented expectations for rate cuts. Meanwhile, the Trump administration is reportedly considering taking a stake in Intel, while Cisco signalled stronger AI-related sales. Oil prices climbed to a one-week high ahead of Trump–Putin talks, and the US dollar strengthened as producer prices surged. Back home, Australian shares are set to open flat ahead of earnings reports from Mirvac and Cochlear. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

The Aussie market kicked off the week on a positive note, with the ASX200 touching another record high before settling about a third of a percent higher, supported by strength in miners and major banks. Lithium stocks surged after reports the world’s biggest EV battery maker may pause operations, while IDP Education jumped on broker upgrades and policy changes for foreign students. JB Hi-Fi slipped despite strong results amid a leadership change. Investors now look ahead to a busy week featuring the RBA’s expected third rate cut of the year, key local jobs and wages data, US inflation figures, and results from major names including CBA, Cochlear, IAG, and Telstra. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice. See omnystudio.com/listener for privacy information.

ASX200: up 0.33%, 8548 GOLD: $3,415 US/ounce BITCOIN: $164,546 The Health Care sector led the way, with stocks up 1.6%, led by CSL, Pro Medicus and Cochlear. James Hardie shares were up 7.1% to $41.70. Brickworks on track to gain in its property division. Shares were up 0.3% to $34.40 Droneshield announced another contract worth $9.7 million, but the company closed the day down more than 4% to $2.28. BHP, Fortescue and Rio Tinto were all down by more than 1%, and also closing lower were Woodside, Xero and Newmont. James Hardie will switch its primary listing to the US as it completes a $14 billion takeover of Azek. See omnystudio.com/listener for privacy information.

Cochlear implants are neat little devices that drastically improve one's quality of life. However, only about 10% of those that qualify for cochlear implants have actually received one. When one thinks of cochlear implants, the first thing that might come to mind is surgery--invasive, lengthy, with a long time of recovery. However, at PNI, patients can expect a much faster, minimally invasive treatment option. Dr. Rebecca Lewis, the Audiology Director of the Adult & Pediatric Cochlear Implant Program, highlights the importance of getting an evaluation done, and early. Studies have shown that the earlier one gets treatment for their hearing issues, the better the outcome. Mathilde Tranberg, an outreach and patient support specialist at PNI, is a cochlear implant recipient herself. As she was implanted as a child, she knows firsthand how helpful it can be. Her goal is to spread the word about cochlear implants through community outreach and education. Listen in and learn about how these innovative devices are changing lives.

Droneshield’s share price has exploded so far this year, so does the threat of war help their outlook? MARKET WRAP: ASX200: down 0.08%, 8541 GOLD: $3,395 US/ounce BITCOIN: $162,400 AUD Santos edged marginally higher to $7.76 despite Federal Treasurer Jim Chalmers warning a $30 billion takeover deal from a UAE based group “has got a long way to run yet”. Gold miners Newmont rose 2.5% and Northern Star rose by 1.5% Uranium stocks were up again, with Deep Yellow up 5.7% and Boss Energy rising more than 3% Life360 was more than 1% higher after a broker upgrade. Pro Medicus dropped just under 1% to $272 a share, while Cochlear dropped 1.6% to $281.66. Genesis Minerals also fell more than 2% to $4.67 James Hardie fell 2.9% to $38.77. CURRENCY UPDATE: AUD/USD: 65.3 AUD/GBP: 48.2 pence AUD/EUR: 56 Euro cents AUD/JPY: 94 yen AUD/NZD: 1.07 Dollars See omnystudio.com/listener for privacy information.

For today's episode of Buy or Sell, Adam Keily is joined by Roger Montgomery, Founder of Montgomery Investment Management.If you want to hear more from Adam Keily, make sure you check our Comedian v Economist (Apple | Spotify)—------Want to get involved in the podcast? Record a voice note or send us a message—------Want more Equity Mates? Across books, podcasts, video and email, however you want to learn about investing - we've got you covered.Keep up with the news moving markets with our daily newsletter and podcast (Apple | Spotify)Check out our latest show: Basis Points (Apple | Spotify | YouTube) and read the accompanying Basis Points email—------Looking for some of our favourite research tools?Read our free ETF Investing HandbookDownload our free 4-step stock checklistFind company information on TIKRScreen the market with GuruFocusTrack your portfolio with Sharesight—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today.—------Equity Mates Investing is a product of Equity Mates Media.This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional.Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Jetstar Asia is being shut down after 20 years of trying to break into the Asia market…and failing Cochlear, the ASX-listed medical device company, has seen its shares take a hit but it’s hoping its bionic ear will save the day Cettire, the online luxury fashion retailer, has seen its shares nosedive 30% after a slowdown in sales, profit and US luxury purchases _ Learn more about iShares by BlackRock here Download the free app (App Store): http://bit.ly/FluxAppStorel Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes. Issued by BlackRock Investment Management (Australia) Limited ABN 13 006 165 975, AFSL 230 523. Refer to FSG available on our website. Before making any investment decisions, you should assess whether the product or service is appropriate for you and read the PDS and TMD available at blackrock.com.au.See omnystudio.com/listener for privacy information.

Following the record high of yesterday and the strong performances over the week the market has paused for breath today and lost some steam as the day went on. Laura and Stevie discuss the slight dip in US markets overnight despite positive trade talks and consumer inflation data that was heading in the right direction, and what could be keeping markets cautious. Monash was in focus again today after news of a resignation, and Cochlear recovered most of the losses that it saw early in the session. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

With consumers in the United States really starting to feel the pinch of tariffs, luxury goods retailers like Cettire could see the pain on their balance sheets sooner rather than later. MARKET WRAP: ASX200: up 0.31%, 8,565 GOLD: $3,360 US/oz BITCOIN: $166,138 AUD Monash IVF CEO Michael Knaap announced his resignation. Shares up 9.1% Cochlear downgraded its guidance, but the market sent the company 0.7% higher to $272.31. Telstra, Transurban, and Coles were all higher. Cettire fell more than 30% after its CEO warned the market of weaker demand from US customers. AGL suffered a swing against it of 0.9% after confirming it could sell its stake in Tilt Renewables. Myer lost 0.7% Sliding more than 1% was BHP, Macquarie, and Goodman. CURRENCY UPDATE: AUD/USD: 64.9 US cents AUD/GBP: 47.9 pence AUD/EUR: 56 Euro cents AUD/JPY: 93 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

Cochlear implants can improve hearing for patients with severe hearing loss. Join Dr. Gerry Clancy and Dr. Alexander Claussen as they discuss how cochlear implants function, how to determine which patients are candidates, and recent advances in the technology. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=xxxxx  Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guest: Alexander D. Claussen, MD Assistant Professor of Otolaryngology/Neurotology University of Iowa Carver College of Medicine Financial Disclosures:   Dr. Claussen has disclosed the following relevant financial relationship: iotaMotion, Inc. - sponsored research Dr. Clancy and the members of the Rounding@IOWA planning committee have disclosed no relevant financial relationships. Relevant financial relationships have been mitigated. Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.5 ANCC contact hour. Pharmacist: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 0.5 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. Pharmacist UAN: JA0000310-0000-25-070-H01-P   Pharmacy Tech UAN: JA0000310-0000-25-070-H01-T Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.) References/Resources:  American Cochlear Implant Alliance Task Force Guidelines for Determining Cochlear Implant Candidacy in Children https://pubmed.ncbi.nlm.nih.gov/35213891/ American Cochlear Implant Alliance Task Force: Recommendations for Determining Cochlear Implant Candidacy in Adults https://pubmed.ncbi.nlm.nih.gov/37435829/  

Cochlear implants remain vastly underutilized despite decades of evidence showing their ability to restore hearing and improve quality of life. In this episode, neurotologist Dr. Varun Varadarajan joins host Brian Taylor to explore the clinical, logistical, and cultural barriers that continue to limit access to cochlear implant care. Drawing on his background in music and neuroscience, Dr. Varadarajan shares his journey into hearing restoration surgery and offers insights into early intervention, the 60/60 referral guideline, and why timing matters for long-term outcomes.The discussion highlights several misconceptions that often delay or prevent patients from seeking cochlear implant evaluation—from concerns about age, surgery, and cost to misunderstandings about candidacy and device function. Dr. Varadarajan stresses the importance of individualized counseling, collaborative decision-making, and helping patients understand that cochlear implantation is a process, not a one-size-fits-all solution. He also addresses myths within the professional community, including hesitancy around residual hearing loss and outdated assumptions about surgical complexity.Beyond clinical considerations, Dr. Varadarajan shares practical strategies for building and expanding cochlear implant programs, including the importance of audiology partnerships, reimbursement planning, and aligning institutional goals. He also explains the value of the Cochlear Provider Network in connecting rural or underserved patients to implant services, and discusses how remote care and virtual follow-up are reshaping postoperative management.Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn and X (formerly Twitter). https://twitter.com/WeekinHearing- https://www.linkedin.com/company/this-week-in-hearing- https://hearinghealthmatters.org/thisweek/

The American Red Cross begins sending teams of volunteers to go to homes to assess flood damage, Buffalo Trace Distillery slowly getting back to business after historic floooding, and Louisville boy talks about life after being the first in the U.S. to receive a new type of cochlear implant. 

In this episode, host Mitch Robbins interviews Mickey Brown, Vice President of Access and Reimbursement at Cerapedics, discussing his 30+ year career journey and insights on healthcare market access.Key Highlights:Mickey shares his transition from 15 years on the payer side (Blue Cross, United Healthcare) to manufacturer roles at Medtronic, Cochlear, and now CerapedicsLearn how stepping outside his comfort zone at critical moments propelled his career forwardDiscover the biggest challenges facing market access professionals in 2025Understand common reimbursement strategy mistakes companies make and how to avoid themPractical Takeaways:Why waiting too long to develop reimbursement strategy hurts product launchesThe key differences between director and VP-level thinkingWhat makes an outstanding market access professionalHow to effectively engage with increasingly inaccessible payersWhether you're in medical device sales, reimbursement, or aspiring to leadership roles in healthcare, this conversation offers valuable insights from both sides of the healthcare ecosystem.

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howitt following the hearing implant maker's profit result on the company's future and US experience; plus Omkar Joshi from Opal Capital Management takes a look at the day on the sharemarke

Lou zeroes in on another self-diagnosis for his mysterious hearing loss and recounts Sebadoh's, first in five years, show in Seattle. Many names are dropped, Adelle is there to pick them up. Also, Lou plays another lo-fi demo for a possible Dinosaur Jr song, Adelle says it's good! watch it on LouTubehttps://youtu.be/Kb4z-mNerTwjoin our Substack!https://substack.com/@barlowfamilygeneral Hosted on Acast. See acast.com/privacy for more information.

Host Christine Blackburn hosts a solo episode about her hearing loss, cochlear implant surgery, and one of her best friends passing away. Listen to Story Worthy anywhere you hear your podcasts! Each week Hollywood's most talented people in the entertainment industry share true, personal stories on the Story Worthy Podcast. Story Worthy celebrates 14 years of podcasting in July 2024 and has over 800 episodes recorded. Christine Blackburn is the creator, host and producer of Story Worthy, Story Smash the Storytelling Game Show, and My Life In 3 Songs exclusively on Spotify. Listen to the entire episode wherever you hear podcasts. If you get a chance, will you please give Story Worthy 5 stars and a good review on Apple Podcasts? It always helps, thank you! And join the mailing list!  Follow Christine's new show, My Life In 3 Songs. Independent Podcast Producer Christine Blackburn talks to comedians about the 3 songs in their lives that have impacted them, not necessarily their favorite songs, but songs that paint a picture of the of the comedian and where they're from. Listen exclusively on Spotify Find My Life In 3 Songs on Insta and at the website ! PLUS! Watch Story Smash The Storytelling Game Show! Comedians spin a wheel and tell TRUE 1-3 minute stories on the topic they land. You can watch episodes from the pandemic and from summer 2023 right now on YouTube. See Story Smash LIVE at the Lyric/Hyperion Theater in Los Angeles now! Check the website for upcoming dates and tickets! And here's Christine  everywhere. THANK YOU!

Imagine a world without sound. No laughter, no music. Cochlear implants are now increasingly covered by insurance in China, suddenly making the unattainable attainable for many. We explore the impact of this change in healthcare policy and learn more about the benefits the patients may enjoy. On the show: Heyang, Steve Hatherly & Yushun

Guest: Melissa Anderson, AuD, CCC-A: This episode explores cochlear nerve deficiency (CND) and its consequences, focusing on using cochlear implants in this population. The guest provides expert insights into counseling and programming, as well as what collaborating on a team to manage these patients looks like.

In a session from Future of Field Service Live in Cologne, Germany, host Sarah Nicastro welcomes back Daniel Trabel, Director of Field Service EMEA at Thermo Fisher Scientific, to discuss how critical a company's talent strategy is to service today and why it demands creativity and a willingness to break free of the status quo to be successful. Daniel is a passionate and visionary leader with a strong track record in clinical diagnostics, life sciences, medical devices, and biotechnology. Before joining Thermo Fisher Scientific, he was a Service Manager at Waters Corporation in Germany South, served as a Service Engineer at Cochlear, and held various key positions at Bio-Rad Laboratories. If you enjoyed this episode, make sure to subscribe, rate, and review on Apple Podcasts, Spotify, and Google Podcasts. Also, subscribe to our newsletter right here: https://www.futureoffieldservice.com/the-insider